Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
Abstract Lymphoma is the most common type of canine hematological malignancy where the multicentric (cMCL) form accounts for 75% of all cases. The standard treatment is the CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone, where the majority of dogs...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f611e4eb68c40a7851795778365a7f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7f611e4eb68c40a7851795778365a7f3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7f611e4eb68c40a7851795778365a7f32021-12-02T12:33:52ZLiquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas10.1038/s41598-020-77366-72045-2322https://doaj.org/article/7f611e4eb68c40a7851795778365a7f32020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77366-7https://doaj.org/toc/2045-2322Abstract Lymphoma is the most common type of canine hematological malignancy where the multicentric (cMCL) form accounts for 75% of all cases. The standard treatment is the CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone, where the majority of dogs achieve complete/partial response; however, it is very important to predict non-responsive cases to improve treatment and to develop new targeted therapies. Here we evaluate a liquid biopsy approach based on serum Small Extracellular Vesicles enriched for exosomes (SEVs) to predict cMCL chemotherapy response. Nineteen dogs at the end of the 19-week chemotherapy protocol (8 Complete Response and 11 Progressive Disease) were evaluated for serum SEVs size, concentration and screened for 95 oncomirs. PD patients had higher SEVs concentration at the diagnosis than CR patients (P = 0.034). The ROC curve was significant for SEVs concentration to predict the response to CHOP (AUC = 0.8011, P = 0.0287). A potential molecular signature based on oncomirs from SEVs (caf-miR-205, caf-miR-222, caf-mir-20a and caf-miR-93) is proposed. To the best of our knowledge, this is the first study demonstrating the potential of a liquid biopsy based on SEVs and their miRNAs content to predict the outcome of chemotherapy for canine multicentric lymphomas.Taismara K. GarnicaJéssika C. C. LesbonAna C. F. C. M. ÁvilaArina L. RochettiOscar R. S. MatizRoana C. S. RibeiroAline ZoppaAdriana T. NishiyaMirela T. CostaAndrigo B. de NardiDavid J. ArgyleRicardo F. StrefezziJuliano C. SilveiraHeidge FukumasuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Taismara K. Garnica Jéssika C. C. Lesbon Ana C. F. C. M. Ávila Arina L. Rochetti Oscar R. S. Matiz Roana C. S. Ribeiro Aline Zoppa Adriana T. Nishiya Mirela T. Costa Andrigo B. de Nardi David J. Argyle Ricardo F. Strefezzi Juliano C. Silveira Heidge Fukumasu Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas |
description |
Abstract Lymphoma is the most common type of canine hematological malignancy where the multicentric (cMCL) form accounts for 75% of all cases. The standard treatment is the CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone, where the majority of dogs achieve complete/partial response; however, it is very important to predict non-responsive cases to improve treatment and to develop new targeted therapies. Here we evaluate a liquid biopsy approach based on serum Small Extracellular Vesicles enriched for exosomes (SEVs) to predict cMCL chemotherapy response. Nineteen dogs at the end of the 19-week chemotherapy protocol (8 Complete Response and 11 Progressive Disease) were evaluated for serum SEVs size, concentration and screened for 95 oncomirs. PD patients had higher SEVs concentration at the diagnosis than CR patients (P = 0.034). The ROC curve was significant for SEVs concentration to predict the response to CHOP (AUC = 0.8011, P = 0.0287). A potential molecular signature based on oncomirs from SEVs (caf-miR-205, caf-miR-222, caf-mir-20a and caf-miR-93) is proposed. To the best of our knowledge, this is the first study demonstrating the potential of a liquid biopsy based on SEVs and their miRNAs content to predict the outcome of chemotherapy for canine multicentric lymphomas. |
format |
article |
author |
Taismara K. Garnica Jéssika C. C. Lesbon Ana C. F. C. M. Ávila Arina L. Rochetti Oscar R. S. Matiz Roana C. S. Ribeiro Aline Zoppa Adriana T. Nishiya Mirela T. Costa Andrigo B. de Nardi David J. Argyle Ricardo F. Strefezzi Juliano C. Silveira Heidge Fukumasu |
author_facet |
Taismara K. Garnica Jéssika C. C. Lesbon Ana C. F. C. M. Ávila Arina L. Rochetti Oscar R. S. Matiz Roana C. S. Ribeiro Aline Zoppa Adriana T. Nishiya Mirela T. Costa Andrigo B. de Nardi David J. Argyle Ricardo F. Strefezzi Juliano C. Silveira Heidge Fukumasu |
author_sort |
Taismara K. Garnica |
title |
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas |
title_short |
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas |
title_full |
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas |
title_fullStr |
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas |
title_full_unstemmed |
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas |
title_sort |
liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/7f611e4eb68c40a7851795778365a7f3 |
work_keys_str_mv |
AT taismarakgarnica liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT jessikacclesbon liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT anacfcmavila liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT arinalrochetti liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT oscarrsmatiz liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT roanacsribeiro liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT alinezoppa liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT adrianatnishiya liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT mirelatcosta liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT andrigobdenardi liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT davidjargyle liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT ricardofstrefezzi liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT julianocsilveira liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas AT heidgefukumasu liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas |
_version_ |
1718393868852920320 |